Hosted on MSN1mon
Arcturus stock holds $63 target amid Japan production noda joint venture established by Arcturus and Axcelead, Inc., and Meiji Seika Pharmatech, a subsidiary of Meiji Seika Pharma. The ARCALIS facilities located in Minami-soma City, Fukushima Prefecture ...
Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the development of infectious disease vaccines and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results